1. Home
  2. LGVN vs BWEN Comparison

LGVN vs BWEN Comparison

Compare LGVN & BWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • BWEN
  • Stock Information
  • Founded
  • LGVN 2014
  • BWEN N/A
  • Country
  • LGVN United States
  • BWEN United States
  • Employees
  • LGVN N/A
  • BWEN N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • BWEN Industrial Machinery/Components
  • Sector
  • LGVN Health Care
  • BWEN Industrials
  • Exchange
  • LGVN Nasdaq
  • BWEN Nasdaq
  • Market Cap
  • LGVN 27.6M
  • BWEN 32.1M
  • IPO Year
  • LGVN 2021
  • BWEN N/A
  • Fundamental
  • Price
  • LGVN $1.61
  • BWEN $1.58
  • Analyst Decision
  • LGVN Strong Buy
  • BWEN Strong Buy
  • Analyst Count
  • LGVN 3
  • BWEN 3
  • Target Price
  • LGVN $8.67
  • BWEN $4.50
  • AVG Volume (30 Days)
  • LGVN 118.8K
  • BWEN 89.7K
  • Earning Date
  • LGVN 05-13-2025
  • BWEN 05-13-2025
  • Dividend Yield
  • LGVN N/A
  • BWEN N/A
  • EPS Growth
  • LGVN N/A
  • BWEN N/A
  • EPS
  • LGVN N/A
  • BWEN 0.05
  • Revenue
  • LGVN $2,392,000.00
  • BWEN $143,136,000.00
  • Revenue This Year
  • LGVN $1.30
  • BWEN $8.78
  • Revenue Next Year
  • LGVN $19.15
  • BWEN $10.05
  • P/E Ratio
  • LGVN N/A
  • BWEN $32.80
  • Revenue Growth
  • LGVN 237.38
  • BWEN N/A
  • 52 Week Low
  • LGVN $0.77
  • BWEN $1.41
  • 52 Week High
  • LGVN $6.40
  • BWEN $4.65
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 55.99
  • BWEN 50.95
  • Support Level
  • LGVN $1.45
  • BWEN $1.51
  • Resistance Level
  • LGVN $1.46
  • BWEN $1.72
  • Average True Range (ATR)
  • LGVN 0.14
  • BWEN 0.09
  • MACD
  • LGVN 0.02
  • BWEN 0.01
  • Stochastic Oscillator
  • LGVN 100.00
  • BWEN 46.15

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.

Share on Social Networks: